03:34 AM EDT, 10/15/2025 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) said late Tuesday it priced a public offering of 11 million common shares at $12 each and, in lieu of common shares to certain investors, pre-funded warrants to purchase up to 1.5 million shares at $11.999 per warrant.

The company expects gross proceeds of $150 million.

The underwriters have been granted a 30-day option to purchase up to about 1.9 million additional shares.

Net proceeds will be used for clinical development, early stage pipeline development and general corporate purposes, the company said.

The offering is expected to close on or about Thursday.